Cargando…
Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing
Heparin is one of the main pharmaceutical products manufactured from raw animal material. In order to describe the viral burden associated with this raw material, we performed high-throughput sequencing (HTS) on mucus samples destined for heparin manufacturing, which were collected from European pig...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International Alliance for Biological Standardization. Published by Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172073/ https://www.ncbi.nlm.nih.gov/pubmed/25466699 http://dx.doi.org/10.1016/j.biologicals.2014.10.004 |
_version_ | 1783524183969366016 |
---|---|
author | Dumarest, Marine Muth, Erika Cheval, Justine Gratigny, Marlène Hébert, Charles Gagnieur, Léa Eloit, Marc |
author_facet | Dumarest, Marine Muth, Erika Cheval, Justine Gratigny, Marlène Hébert, Charles Gagnieur, Léa Eloit, Marc |
author_sort | Dumarest, Marine |
collection | PubMed |
description | Heparin is one of the main pharmaceutical products manufactured from raw animal material. In order to describe the viral burden associated with this raw material, we performed high-throughput sequencing (HTS) on mucus samples destined for heparin manufacturing, which were collected from European pigs. We identified Circoviridae and Parvoviridae members as the most prevalent contaminating viruses, together with viruses from the Picornaviridae, Astroviridae, Reoviridae, Caliciviridae, Adenoviridae, Birnaviridae, and Anelloviridae families. Putative new viral species were also identified. The load of several known or novel small non-enveloped viruses, which are particularly difficult to inactivate or eliminate during heparin processing, was quantified by qPCR. Analysis of the combined HTS and specific qPCR results will influence the refining and validation of inactivation procedures, as well as aiding in risk analysis of viral heparin contamination. |
format | Online Article Text |
id | pubmed-7172073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The International Alliance for Biological Standardization. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71720732020-04-22 Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing Dumarest, Marine Muth, Erika Cheval, Justine Gratigny, Marlène Hébert, Charles Gagnieur, Léa Eloit, Marc Biologicals Article Heparin is one of the main pharmaceutical products manufactured from raw animal material. In order to describe the viral burden associated with this raw material, we performed high-throughput sequencing (HTS) on mucus samples destined for heparin manufacturing, which were collected from European pigs. We identified Circoviridae and Parvoviridae members as the most prevalent contaminating viruses, together with viruses from the Picornaviridae, Astroviridae, Reoviridae, Caliciviridae, Adenoviridae, Birnaviridae, and Anelloviridae families. Putative new viral species were also identified. The load of several known or novel small non-enveloped viruses, which are particularly difficult to inactivate or eliminate during heparin processing, was quantified by qPCR. Analysis of the combined HTS and specific qPCR results will influence the refining and validation of inactivation procedures, as well as aiding in risk analysis of viral heparin contamination. The International Alliance for Biological Standardization. Published by Elsevier Ltd. 2015-01 2014-11-15 /pmc/articles/PMC7172073/ /pubmed/25466699 http://dx.doi.org/10.1016/j.biologicals.2014.10.004 Text en Copyright © 2014 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Dumarest, Marine Muth, Erika Cheval, Justine Gratigny, Marlène Hébert, Charles Gagnieur, Léa Eloit, Marc Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title | Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title_full | Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title_fullStr | Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title_full_unstemmed | Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title_short | Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
title_sort | viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172073/ https://www.ncbi.nlm.nih.gov/pubmed/25466699 http://dx.doi.org/10.1016/j.biologicals.2014.10.004 |
work_keys_str_mv | AT dumarestmarine viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT mutherika viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT chevaljustine viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT gratignymarlene viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT hebertcharles viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT gagnieurlea viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing AT eloitmarc viraldiversityinswineintestinalmucususedforthemanufactureofheparinasanalyzedbyhighthroughputsequencing |